Citalopram Neuropharmacological Challenge in Alcohol-Dependent Patients and Controls: Pharmacogenetic, Endocrine and Psychobehavioral Results

Abstract

Aim: Alcoholism has been associated with long-lasting alterations in LHPA (limbic-hypothalamus-pituitary-adrenal) axis function, related to a dysfunction of the serotonergic neurotransmission. Functional polymorphisms of the serotonin system were previously reported to have significant influence on serotonin-induced neuroendocrine response. The aim of the study is to investigate in a double-blind, placebo-controlled approach, whether citalopram (a selective serotonin reuptake inhibitor, SSRI) would affect LHPA axis function as measured with ACTH (adrenocorticotrophic hormone) levels representing endocrine responsivity in 11 alcohol-dependent individuals compared to 12 controls. Furthermore we wanted to know whether functional polymorphisms (5-HTTLPR and 5HT2C Ser23Cys), have any influence on this responsivity.

Patients and Methods: Alcohol-dependent inpatients aged 36.45±7.7 years who were de-toxified, without comorbid psychiatric/medical disorders or concurrent psychotropic medications, and 12 age-matched healthy controls aged 32.50±6.4 years were enrolled. Subjects also reported their subjective experiences like anxiety, craving and intoxication using visual analogue scales (VAS), side-effects were assessed by the serotonin syndrome scale (SSS). Measurements were taken at 8 timepoints at 30 mins interval, from -2 (60 mins pre-application) to +6 (180 mins post-application). Patients had a mean duration of illness of 8.91±3.4 years, consumed a mean of 326.36±220.8 g alcohol/day whereas control subjects consumed a mean of 32.50±41.4 g alcohol/day. A 0.4 mg citalopram/kg body weight dose was administered intravenously to patients (31.96±4.45 mg), and to controls (34.22±7.65 mg).

Results: ACTH levels were higher for both groups in the verum compared to placebo administrations across timepoints. 5HT2C Ser23 alleles effected significantly higher ACTH responses under placebo administration but attenuated the responses under citalopram adminsitration. Considering both groups together, no influence of 5-HTTLPR alleles was found on ACTH levels in either group under either regimen. While citalopram adminsitration did not reduce craving in alcohol-dependent patients, it increased anxiety in patients and controls compared to placebo adminstration.

Conclusion: Despite the small differences in endocrine and subjective responses between alcoholic patients and controls, the effect of SSRI on endocrine response with respect to 5HT2C functional alleles deserves further investigation in larger samples to clarify whether this genetic variant constitutes a potential risk factor for changes in neuroendocrine functioning and subsequent psychiatric disorders.

References

• 1 Adinoff B, Junghanns K. et al . Suppression of the HPA axis stress-response: implications for relapse.  Alcohl Clin Exp Res. 2005;  29 1351-1355
• 2 Adinoff B, Ruether K. et al . Increased salivary cortisol concentrations during chronic alcohol intoxication in a naturalistic clinical sample of men.  Alcohol Clin Exp Res. 2003;  27 1420-1427
• 3 Angelone SM, Bellini L. et al . Effects of fluvoxamine and citalopram in maintaining abstinence in a sample of Italian detoxified alcoholics.  Alcohol. 1988;  33 151-156
• 4 Bucholz KK, Cadoret R. et al . A new, semi-structured psychiatric interview for use in genetic linkage studies: A report on the reliability of the SSAGA.  J Stud Alcohol. 1995;  55 149-158
• 5 Cook EH, Courchensne R. et al . Evidence of linkage between the serotonin transporter and autistic disorder.  Mol Psychiatry. 1997;  2 247-250
• 6 Done CJ, Sharp T. Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: microdialysis studies in the awake and anaesthetized rat.  Neuropharmacology. 1994;  33 411-421
• 7 Doudet D, Hommer D. et al . Cerebral glucose metabolism, CSF 5-HIAA levels, and aggressive behavior in rhesus monkeys.  Am J Psychiatry. 1995;  152 1782-1787
• 8 Ehrenreich H, Schuck J. et al . Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence.  Alcohol Clin Exp Res. 1997;  21 1285-1293
• 9 Errico AL, Parson OA. et al . Attenuated cortisol response to biobehavioral stressors in sober alcoholics.  J Stud Alcohol. 1993;  54 393-398
• 10 Farren CK, O’Malley SS. et al . Variable dose naltrexone-induced hypothalamic-pituitary-adrenal stimulation in abstinent alcoholics: a preliminary study.  Alcohl Clin Exp Res. 1999;  23 502-508
• 11 Geracioti TD, Goldsmith RJ. et al . Cerebrospinal fluid neuroendo-crinology of alcohol misusers.  Addict Biol. 1997;  2 401-409
• 12 Geracioti TD, Loosen PT. et al . Concentrations of corticotropin-releasing hormone, norepinephrine, MHPG, 5-hydroxyindoleacetic acid, and tryptophan in the cerebrospinal fluid of alcoholic patients: Serial sampling studies.  Neuroendocrinology. 1994;  60 635-642
• 13 Heinz A, Jones DW. et al . A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity.  Biol Psychiatry. 2000;  47 643-649
• 14 Heinz A, Ragan P. et al . Reduced central serotonin transporters in alcoholism.  Am J Psychiatry. 1998;  155 1544-1549
• 15 Jönsson EG, Melke BJ, Abou Jamra R, Schumacher J, Westberg L, Ivo R, Cichon S, Propping P, Nothen MM, Eriksson E, Sedvall GC. Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers.  BMC Psychiatry. 2004;  4 4
• 16 Jönsson EG, Nothen MM, Gustavsson JP. et al . Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers.  Psychiatry Res. 1998;  79 1-9
• 17 Keedwell PA, Poon L. et al . Salivary cortisol measurements during a medically assisted alcohol withdrawal.  Addict Biol. 2001;  6 247-256
• 18 Lappalainen J, Long JC, Virkkunen M, Ozaki N, Goldman D, Linnoila M. HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses.  Biol Psychiatry. 1999;  46 821-826
• 19 LeMarquand D, Phil RO. et al . Serotonin and alcohol intake, abuse and dependence: findings of animal studies.  Biol Psychiatry. 1994;  36 395-421
• 20 Lovallo WR, Dickensheets SL. et al . Blunted stress cortisol response in abstinent alcoholic and polysubstance-abusing men.  Alcoholism: Clin Exp Res. 2000;  24 651-658
• 21 Mihic SH, Ye Q. et al . Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors.  Nature. 1997;  389 385-389
• 22 Miksys S, Rao Y, Hoffmann E, Mash DC, Tyndale RF. Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics.  J Neurochem. 2002;  82 1376-1387
• 23 Milatovich A, Hsieh CL, Bonaminio G, Tecott L, Julius D, Francke U. Serotonin receptor 1c gene assigned to X chromosome in human (band q24) and mouse (bands D-F4).  Hum Mol Genet. 1992;  1 681-684
• 24 Moss HB, Yao JK. et al . Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse.  Biol Psychiatry. 1990;  28 325-338
• 25 Naranjo CA, Brenner KE. et al . Effects of citalopram and a brief psychosocial intervention on alcohol intake, dependence and problems.  Addiction. 1995;  90 87-99
• 26 Okada M, Northrup J, Ozaki N, Russell JT, Linnoila M, Goldman D. Modification of human 5-HT(2C) receptor function by Cys23Ser, an abundant, naturally occurring amino-acid substitution.  Mol Psychiatry. 2004;  9 55-64
• 27 Schuckit MA, Smith TL. An 8-year follow-up of 450 sons of alcoholic and control subjects.  Arch Gen Psychiatry. 1996;  53 202-210
• 28 Schurmeyer TH, Brademann G. et al . Effect of fenfluramine on episodic ACTH and cortisol secretion.  Clin Endocrinol. 1996;  45 39-45
• 29 Tiihonen J, Ryyanen OP. et al . Citalopram in the treatment of alcoholism: a double-blind, placebo-controlled study.  Pharmacopsychiatry. 1996;  29 27-29
• 30 Vescovi PP, DiGennaro C. et al . Hormonal (ACTH, cortisol, beta-endorphin, and met-enkephalin) and cardiovascular responses to hyperthermic stress in chronic alcoholics.  Alcohol Clin Exp Res. 1997;  21 1195-1198
• 31 Virkkunen M, Linnoila M. Brain serotonin, type II alcoholism and impulsive violence.  Journal of Studies on Alcohol. 1993;  ((Suppl 11)) 163-169
• 32 Marchesi C, Cantoni A, Fonto S, Giannelli MR, Maggini C. Predictors of symptom resolution in panic disorder after one year of pharmacological treatment: a naturalistic study.  Pharmacopsychiatry. 2006;  39 60-65

Correspondence